Have a personal or library account? Click to login
Bilateral renal angiomyolipomas and subependymal giant cell astrocytoma associated with tuberous sclerosis complex: A case report and review of the literature Cover

Bilateral renal angiomyolipomas and subependymal giant cell astrocytoma associated with tuberous sclerosis complex: A case report and review of the literature

Balkan Journal of Medical Genetics
Volume 23 (2020): Issue 2 (November 2020)
By: I Rambabova Bushljetik,  M Lazareska,  I Barbov,  O Stankov,  V Filipce and  G Spasovski  
Open Access
|Mar 2021

References

  1. O’Callaghan FJ, Shiell AW, Osborne JP, Martyn CN. Prevalence of tuberous sclerosis estimated by capture-recapture analysis. Lancet. 1998; 351(9114): 1490.
    Search in Google ScholarBack to article
  2. Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006; 355(13): 1345-1356.
    Search in Google ScholarBack to article
  3. Jansen FE, van Nieuwenhuizen O, van Huffelen AC. Tuberous sclerosis complex and its founders. J Neurol Neurosurg Psychiatry. 2004; 75(5): 770.
    Search in Google ScholarBack to article
  4. Brigo F, Lattanzi S, Trinka E, Nardone R, Bragazzi NL, Ruggieri M, et al. First descriptions of tuberous sclerosis by Désiré-Magloire Bourneville (18401909. Neuro-pathology. 2018; 38(6):577-582.
    Search in Google ScholarBack to article
  5. Rodrigues DA, Gomes CM, Costa IM. Tuberous sclerosis complex. Ann Bras Dermatol. 2012; 87(2): 184-196.
    Search in Google ScholarBack to article
  6. Portocarrero LKL, Quental KN, Samorano LP, de Oliveira ZNP, Rivitti-Machado MCDM. Tuberous sclerosis complex: review based on new diagnostic criteria. Ann Bras Dermatol. 2018; 93(3): 323-331.
    Search in Google ScholarBack to article
  7. Pirson Y. Tuberous sclerosis complex-associated kidney angiomyolipoma: From contemplation to action. Nephrol Dial Transplant. 2013; 28(7): 1680-1685.
    Search in Google ScholarBack to article
  8. Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: Revised clinical diagnostic criteria. J Child Neurol. 1998; 13(12): 624-628.
    Search in Google ScholarBack to article
  9. Northrup H, Krueger DA; International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013; 49(4): 243-254.
    Search in Google ScholarBack to article
  10. Gabardi S, Baroletti SA Everolimus: A proliferation signal inhibitor with clinical applications in organ transplantation, oncology, and cardiology. Pharma-cotherapy. 2010; 30(10): 1044-1056.
    Search in Google ScholarBack to article
  11. Capal JK, Franz DN. Profile of everolimus in the treatment of tuberous sclerosis complex: An evidence-based review of its place in therapy. Neuropsychiatr Dis Treat. 2016; 12: 2165-2172.
    Search in Google ScholarBack to article
  12. Curatolo P, Moavero R, de Vries PJ. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol. 2015; 14(7): 733-745.
    Search in Google ScholarBack to article
  13. Budde K, Gaedeke J. Tuberous sclerosis complex-associated angiomyolipomas: Focus on mTOR inhibition. Am J Kidney Dis. 2012; 59(2): 276-283.
    Search in Google ScholarBack to article
  14. McCormack FX, Inoue Y, Moss J, Singer LG, Strange C, Nakata K, et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med. 2011; 364(17): 1595-1606.
    Search in Google ScholarBack to article
  15. Jacks SK, Witman PM. Tuberous sclerosis complex: An update for dermatologists. Pediatr Dermatol. 2015; 32(5): 563-570.
    Search in Google ScholarBack to article
  16. Murray TE, Doyle F, Lee M. Transarterial embolization of angiomyolipoma: A systematic review. J Urol. 2015; 194(3): 635-639.
    Search in Google ScholarBack to article
  17. Franz DN, Belousova E, Sparagana S, Bebin EM, Frost M, Kuperman R, et al. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): A multicentre, randomised, placebo-controlled phase 3 trial. Lancet. 2013; 381(9861): 125-132.
    Search in Google ScholarBack to article
  18. Bissler JJ, Kingswood JC, Radzikowska E, Zonnenberg BA, Frost M, Belousova E, et al. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): A multicentre, randomised, double-blind, placebocontrolled trial. Lancet. 2013; 381(9869): 817-824.
    Search in Google ScholarBack to article
  19. Bissler JJ, Kingswood JC, Radzikowska E, Zonnenberg BA, Belousova E, Frost MD, et al. Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study. PLoS One. 2017; 12(8): e0180939.
    Search in Google ScholarBack to article
  20. Toriu N, Mizuno H, Sawa N, Sumida K, Suwabe T, Hayami N, et al. Everolimus reduces the size of tuberous sclerosis complex-related huge renal angiomyolipomas exceeding 20 cm in the longest diameter. Case Rep Oncol. 2018; 11(2): 258-267.
    Search in Google ScholarBack to article
  21. Kotulska K, Borkowska J, Roszkowski M, Mandera M, Daszkiewicz P, Drabik K, et al., Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients. Pediatr Neurol. 2014; 50(4): 307–312.
    Search in Google ScholarBack to article
  22. Roth J, Roach ES, Bartels U, Jóźwiak S, Koenig MK, Weiner HL, et al.. Subependymal giant cell astrocytoma: Diagnosis, screening, and treatment. Recommendations from the International Tuberous sclerosis Complex Consensus Conference 2012. Pediatr Neurol. 2013; 49(6): 439-444.
    Search in Google ScholarBack to article
  23. Stein JR, Reidman DA. Imaging manifestations of a subependymal giant cell astrocytoma in tuberous sclerosis. Case Rep Radiol. 2016; 2016: 3750450.
    Search in Google ScholarBack to article
DOI: https://doi.org/10.2478/bjmg-2020-0017 | Journal eISSN: 2199-5761
Journal RSS Feed
Language: English
Page range: 93 - 98
Published on: Mar 23, 2021
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Tuberous sclerosis complex (TSC),
Angiomyolipoma (AML),
Subependymal giant cell astrocytoma (SEGA),
Everolimus (EVE)
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2021 I Rambabova Bushljetik, M Lazareska, I Barbov, O Stankov, V Filipce, G Spasovski, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 23 (2020): Issue 2 (November 2020)Next article